title: Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group.
authors.affiliation: Dept of Surgery, School of Medicine, Chiba University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Ochiai
authors.forename: K
authors.initials: K
authors.lastname: Fukao
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: T
authors.initials: T
authors.lastname: Endo
authors.forename: S
authors.initials: S
authors.lastname: Oshima
authors.forename: K
authors.initials: K
authors.lastname: Uchida
authors.forename: I
authors.initials: I
authors.lastname: Yokoyama
authors.forename: M
authors.initials: M
authors.lastname: Ishibashi
authors.forename: S
authors.initials: S
authors.lastname: Takahara
authors.forename: Y
authors.initials: Y
authors.lastname: Iwasaki
mesh_terms: D001424:Bacterial Infections / Q000453:epidemiology; D001794:Blood Pressure; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D009181:Mycoses / Q000453:epidemiology; D018579:Patient Selection; D011183:Postoperative Complications / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D014019:Tissue Donors; D014777:Virus Diseases / Q000453:epidemiology
chemical_list: D016572:Cyclosporine; D011239:Prednisolone; D016559:Tacrolimus